Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

CHD4 ensures stem cell lineage fidelity during skeletal muscle regeneration.

Autor: Sreenivasan K; Department of Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany., Rodríguez-delaRosa A; Department of Experimental & Health Sciences, University Pompeu Fabra (UPF), CIBERNED, 08003 Barcelona, Spain., Kim J; Department of Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany; German Center for Cardiovascular Research (DZHK), Rhine Main, Germany., Mesquita D; Department of Experimental & Health Sciences, University Pompeu Fabra (UPF), CIBERNED, 08003 Barcelona, Spain., Segalés J; Department of Experimental & Health Sciences, University Pompeu Fabra (UPF), CIBERNED, 08003 Barcelona, Spain., Arco PG; Institute of Rare Diseases Research, Instituto de Salud Carlos III (ISCIII), 28220 Majadahonda, Madrid, Spain; Gene Regulation in Cardiovascular Remodelling & Inflammation Laboratory, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), 28029 Madrid, Spain., Espejo I; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Barcelona, 08003 Barcelona, Spain., Ianni A; Department of Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany., Di Croce L; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Barcelona, 08003 Barcelona, Spain; Department of Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany; ICREA, 08010 Barcelona, Spain., Relaix F; Univ Paris Est Creteil, INSERM, EnvA, EFS, AP-HP, IMRB, F-94010 Creteil, France., Redondo JM; Gene Regulation in Cardiovascular Remodelling & Inflammation Laboratory, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), 28029 Madrid, Spain., Braun T; Department of Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany; German Center for Cardiovascular Research (DZHK), Rhine Main, Germany; German Center for Lung Research (DZL), Giessen, Germany., Serrano AL; Department of Experimental & Health Sciences, University Pompeu Fabra (UPF), CIBERNED, 08003 Barcelona, Spain. Electronic address: antonio.serrano@upf.edu., Perdiguero E; Department of Experimental & Health Sciences, University Pompeu Fabra (UPF), CIBERNED, 08003 Barcelona, Spain. Electronic address: eusebio.perdiguero@upf.edu., Muñoz-Cánoves P; Department of Experimental & Health Sciences, University Pompeu Fabra (UPF), CIBERNED, 08003 Barcelona, Spain; ICREA, 08010 Barcelona, Spain; Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain. Electronic address: pura.munoz@upf.edu.

Publikováno v: Stem cell reports [Stem Cell Reports] 2021 Sep 14; Vol. 16 (9), pp. 2089-2098. Date of Electronic Publication: 2021 Aug 26.

Selective inhibition of plasma membrane calcium ATPase 4 improves angiogenesis and vascular reperfusion.

Autor: Kurusamy S; Cardiovascular Molecular Pharmacology Laboratory, School of Pharmacy, University of Wolverhampton, Wolverhampton, UK., López-Maderuelo D; Gene Regulation in Cardiovascular Remodelling and Inflammation Group, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain; CIBERCV, Spain., Little R; Division of Cardiovascular Sciences, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK., Cadagan D; Cardiovascular Molecular Pharmacology Laboratory, School of Pharmacy, University of Wolverhampton, Wolverhampton, UK., Savage AM; Department of Infection, Immunity & Cardiovascular Disease & Bateson Centre, University of Sheffield, UK., Ihugba JC; Cardiovascular Molecular Pharmacology Laboratory, School of Pharmacy, University of Wolverhampton, Wolverhampton, UK., Baggott RR; Cardiovascular Molecular Pharmacology Laboratory, School of Pharmacy, University of Wolverhampton, Wolverhampton, UK., Rowther FB; Brain Tumor UK Neuro-oncology Research Centre, University of Wolverhampton, Wolverhampton, UK., Martínez-Martínez S; Gene Regulation in Cardiovascular Remodelling and Inflammation Group, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain; CIBERCV, Spain., Arco PG; Gene Regulation in Cardiovascular Remodelling and Inflammation Group, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain; CIBERCV, Spain; Department of Molecular Biology, Universidad Autonoma de Madrid (C.B.M.S.O.), Madrid, Spain., Murcott C; Cardiovascular Molecular Pharmacology Laboratory, School of Pharmacy, University of Wolverhampton, Wolverhampton, UK., Wang W; Oncology Laboratory, Research Institute in Healthcare Science, Faculty of Science and Engineering, University of Wolverhampton, Wolverhampton, UK., Francisco Nistal J; Cardiovascular Surgery, Hospital Universitario Marqués de Valdecilla, IDIVAL, Facultad de Medicina, Universidad de Cantabria, Santander, Spain., Oceandy D; Division of Cardiovascular Sciences, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK., Neyses L; Division of Cardiovascular Sciences, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK; University of Luxembourg, Luxembourg., Wilkinson RN; Department of Infection, Immunity & Cardiovascular Disease & Bateson Centre, University of Sheffield, UK., Cartwright EJ; Division of Cardiovascular Sciences, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK., Redondo JM; Gene Regulation in Cardiovascular Remodelling and Inflammation Group, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain; CIBERCV, Spain. Electronic address: jmredondo@cnic.es., Armesilla AL; Cardiovascular Molecular Pharmacology Laboratory, School of Pharmacy, University of Wolverhampton, Wolverhampton, UK; CIBERCV, Spain. Electronic address: A.Armesilla@wlv.ac.uk.

Publikováno v: Journal of molecular and cellular cardiology [J Mol Cell Cardiol] 2017 Aug; Vol. 109, pp. 38-47. Date of Electronic Publication: 2017 Jul 03.

Dithiocarbamates trigger differentiation and induction of CD11c gene through AP-1 in the myeloid lineage.

Autor: Aragonés J; Servicio de Inmunología y Biología Molecular del Hospital de la Princesa, Madrid, Spain., López-Rodríguez C, Corbí A, del Arco PG, López-Cabrera M, de Landázuri MO, Redondo JM

Publikováno v: The Journal of biological chemistry [J Biol Chem] 1996 May 03; Vol. 271 (18), pp. 10924-31.